LEO 124249 Ointment in the Treatment of Alopecia Areata

Last Updated:
08/16/2016
Status:
Completed
Country:
United States
Eligibility:
Age 18-65; diagnosed with moderate to severe patch type alopecia areata
Drug:
LEO 124249 Ointment
Administration:
Topical
Sponsor: 
LEO Pharma

The purpose of this study is to investigate the efficacy and safety of LEO 124249 in the treatment of alopecia areata.

The following research centers are looking for volunteers to participate in this study that will use an investigational topical product for alopecia areata:

Northwestern University
Evanston, Illinois
Phone: 312-695-3613

The Icahn School of Medicine, Mount Sinai Hospital
New York, New York
Phone: 212-241-3288